EP0944352A1 - Non-invasive cuffless determination of blood pressure - Google Patents

Non-invasive cuffless determination of blood pressure

Info

Publication number
EP0944352A1
EP0944352A1 EP97910095A EP97910095A EP0944352A1 EP 0944352 A1 EP0944352 A1 EP 0944352A1 EP 97910095 A EP97910095 A EP 97910095A EP 97910095 A EP97910095 A EP 97910095A EP 0944352 A1 EP0944352 A1 EP 0944352A1
Authority
EP
European Patent Office
Prior art keywords
pressure
blood volume
determining
ekg
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP97910095A
Other languages
German (de)
French (fr)
Other versions
EP0944352B1 (en
Inventor
Howard L. Golub
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DxTek Inc
Original Assignee
DxTek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DxTek Inc filed Critical DxTek Inc
Publication of EP0944352A1 publication Critical patent/EP0944352A1/en
Application granted granted Critical
Publication of EP0944352B1 publication Critical patent/EP0944352B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/02108Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
    • A61B5/02125Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics of pulse wave propagation time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • A61B5/0285Measuring or recording phase velocity of blood waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346Analysis of electrocardiograms
    • A61B5/349Detecting specific parameters of the electrocardiograph cycle
    • A61B5/352Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval

Definitions

  • A-lines which are used when continuous measurement is necessary, are reasonably accurate during periods free from signal artifact, from sources such as line-crimping, blood-clotting, and conta ⁇ between the indwelling transducer and the arterial wall.
  • the transducer needs to be inserted surgically, and can cause thrombosis and infection. Because the method necessitates a surgical procedure, it is used sparingly, and frequently not recommended for use even when continuous pressure measurement would otherwise be desirable.
  • the experimental methods noted all attempt to circumvent the drawbacks of the A-line by measuring continuous blood pressure externally. Both direct external pressure sensing and indirect calculation methods have been devised. The direct non-invasive methods use external pressure transduction.
  • a pressure transducer is placed against an artery that lies just beneath the skin, such as the radial artery, and by pushing against the arterial wall senses pressure mechanically.
  • the transducer is sensing force, it is extremely subject to mechanical noise and motion artifact.
  • Continuous measurement is problematical in that the transducer impedes blood flow. Difficulty also arises in keeping the transducer positioned properly over the artery. Thus, indirect- measurement methods have been considered.
  • Pulse-wave transit-time measurement is an indirect way of inferring arterial blood pressure from the velocity of the pulse wave produced at each heart cycle, however, though the velocity is related to blood pressure, the methods devised to date assume that the relationship is linear, and even if that were the case, it is probable that transit time by itself provides too little information about the pulse wave to permit the determination of blood pressure accurately.
  • Another shortcoming of the method is that it is incapable of giving pressures at both systole and diastole, which many medical practitioners find useful.
  • Photoplethysmography a technique of tracking arterial blood-volume and blood oxygen content, gives rise to the other indirect way of inferring blood pressure continuously.
  • the methods based on it derive information from the volumetric data as though it were the same as blood pressure; that is, they assume that blood-pressure and blood-volume curves are similar - which is true sometimes but not in general.
  • photoplethysmographic measurements are made at bodily extremities such as the earlobe or finger, and blood pressure observed at the body's periphery is not generally the same as from more central measurements.
  • the method according to the invention for determining arterial blood pressure in a subject includes detecting an EKG signal for the subject.
  • a fiducial point on the EKG signal is selected and the blood volume versus time wave shape at a selected location on the subject's body is monitored.
  • Instantaneous heart rate is determined from the EKG signal and arterial pressure is calculated from the instantaneous heart rate and the blood volume versus time wave shape.
  • the fiducial point is the R-wave and arterial pressure is calculated utilizing a selected change in blood volume from the blood volume versus time wave shape. It is preferred that the selected change in blood volume be in the range of 20% to 80% on the upslope on the wave shape. It is more preferred that the selected change in blood volume is in the range of 40% to 60%. The most preferred selected change in blood volume is approximately 50% on the upslope of the volume waveform. It is preferred that the selected body portion is a distal location such as a fingertip.
  • the method according to the invention for determining arterial blood pressure in a subject includes detecting an EKG for the subject and selecting a fiducial point on the EKG during the pulse period. Blood volume versus time is monitored at a selected location on the subject's body. The time difference between occurrence of the selected fiducial point on the EKG and occurrence of a selected change in blood volume at the selected body location is determined. Heart rate is determined from the EKG and arterial pressure is computed based on the time difference and heart rate.
  • the fiducial point is the R-wave and the body portion is a distal location such as a fingertip.
  • a preferred method for monitoring blood volume utilizes photoplethysmography.
  • the computed arterial pressure may be diastolic pressure, systolic pressure, or mean arterial pressure.
  • Apparatus responsive to change in blood volume may include photoplethysmography apparatus. Outputs from the EKG apparatus and the blood volume monitoring apparatus are introduced into a signal processor or computer which computes arterial blood pressure.
  • the signal processing and computing apparatus is adapted to detect artifacts in the blood pressure measurement and to reject such artifacts.
  • These techniques allow for the reliable assessment of the confidence of the blood pressure calculation for each pulse.
  • the techniques disclosed herein provide a much more reliable measure of blood pressure during times of good input signal and informs the user that there are no available measures during times of poor input signal quality.
  • the present invention provides an improved method and apparatus for measuring arterial blood pressure continuously, non-invasively, and without the use of a blood pressure cuff. Because of the automated artifact detection and rejection, a reliable assessment of the confidence of the blood pressure computation for each pulse can be made.
  • Fig. 1 is a schematic illustration of the apparatus of the present invention.
  • Fig. 2 is a graph of EKG and blood volume versus time.
  • c is the wave velocity
  • E and h are Young's modulus and thickness of the arterial wall
  • the density of the fluid
  • R the mean radius of the tube.
  • V is the initial volume of the artery
  • ⁇ V is the change in volume resulting in the pressure pulse ⁇ P
  • c is the pulse wave velocity
  • the problem then involves determining a non-invasive way of measuring both the pulse wave velocity, and percent change in arterial volume.
  • the method of utilizing the EKG signal and blood volume versus time signals include first measuring the T R ⁇ (duration of R-wave on EKG to 50% point on volume versus time up-slope) for the i'th pulse. This duration is the sum of the time between the R-wave and the arrival of the pulse 0% point (T R 0(l) ) added to the duration of the pulse 0% point to the 50% point on the up-slope (T 0 _ ⁇ ).
  • the measure T R 50( , ) is a measure that is related to c, ⁇ V and V. Then, the combined pulse velocity measure for the i'th pulse (v p ⁇ ) is therefore equal to the inverse of T R 50W and the combined pulse velocity squared (v p ⁇ 2 ) is obtained by simply squaring v Q . Also the instantaneous R-R interval and thereby instantaneous heart rate for the i'th pressure pulse (RR, and IHR W respectively) are determined and used in the calculation of diastolic, systolic and mean pressures for the i'th pulse (P D(
  • the diastolic pressure is defined as that arterial pressure that exists at the end of the diastolic pressure decay. This exponential diastolic pressure decay starts at the closure of the aortic valve, and ends at the opening of the aortic valve.
  • the pressure decay rate depends on a variety of factors, including the aortic pressure built up during systole, and the systemic arterial impedance (related to the stiffness of the walls of the arterial system, especially the arteriole). For a given individual, the pressure this decay falls to for any given heart beat (or diastolic pressure) is therefore related to the duration this decay is allowed to continue.
  • This duration of decay for any given pulse is directly proportional to the instantaneous R-R interval or inversely proportional to the IHR of that pulse. Therefore, the shorter the decay duration (higher IHR), the higher the diastolic pressure is expected to be, and the longer the decay duration (lower IHR), the lower the diastolic pressure is expected to be.
  • the equations for the calculation of pressures for the i'th pressure pulse are as follows:
  • IHR (1) 1/RR (1)
  • v p(l) 2 ( 1/T R 50(1) ) * ( 1/T R 50(1) )
  • K Dv , K Dlhr and K ⁇ are constants that in the preferred embodiment are equal to 2.5, 0.5 and 35 respectively, and where K Dca ⁇ and K Sca! are calibration constants.
  • P D( , ) , P ⁇ and P M( are diastolic, systolic and mean arterial pressure respectively.
  • a human subject 10 is monitored by EKG leads represented generally at 12.
  • EKG leads represented generally at 12.
  • Photoplethysmography apparatus 14 monitors blood volume at a fingertip 16 of the subject 10.
  • the outputs from the EKG apparatus 12 and photoplethysmography apparatus 14 are processed in a computer or signal processor 18 and produces as an output blood pressure which, as discussed above, may be diastolic pressure, systolic pressure or mean arterial pressure for each pulse.
  • the processor 18 detects the R-wave arrival.
  • the blood volume measuring apparatus 14 detects the onset of a change in volume at time T R 0 Q and determines the time when volume has reached the 50% (T 0 ⁇ point on the volume versus time upslope.
  • T R 0 the time from the arrival of the pulse zero percent point (T R 0(l) ) to the 50% point on the upslope (T 0 ⁇ depends on the shape of the volume versus time curve. Because the present invention utilizes both the time from R-wave arrival to the zero percent volume change point, and from the zero percent volume change point to the 50% point, pressure determinations are more accurate than in the prior art in which either pulse arrival time or wave shape was utilized but not both in combination as in the present invention.
  • Another aspect of the invention includes methods for automated artifact dete ⁇ ion and reje ⁇ ion thereby providing a reliable assessment of the confidence of each blood pressure calculation for each pulse.
  • the algorithm includes whether: qv p(l) 2 > THRESH_qv or p D(l) ⁇ PD ⁇ OOLOW or
  • the artifa ⁇ determination for P s(]) calculation includes whether: qv p(l) 2 > THRESH_qv or diffv p(l) 2 > THRESH_diffv or

Abstract

Arterial blood pressure of a subject is determined by detecting the EKG for the subject and selecting a fiducial point on the EKG during a pulse. Apparatus is provided for monitoring blood volume versus time at a selected location on the subject's body such as a fingertip. A time difference between the occurrence of the selected fiducial point on the EKG and a selected change in blood in volume at the selected body location is determined. This time difference depends on the arrival time of the pulse at the distal location in addition to the shape of the blood volume versus time curve. Heart rate is determined from the EKG. The arterial pressure is computed from pulse arrival time, volumetric wave shape and instantaneous heart rate for each pulse. It is preferred that the fiducial point on the EKG be an R-wave. A suitable method for determining change in blood volume utilizes photoplethysmography. Methods are disclosed for determining diastolic pressure, systolic and mean arterial pressure. In another aspect, artifact detection and rejection enabled. The invention provides for a continuous measure of blood pressure in a non-invasive, cuffless manner.

Description

NON-INVASIVE CUFFLESS DETERMINATION OF BLOOD PRESSURE
Background of the Invention Several distinct arterial blood-pressure parameters yield medically useful information, among them pressure at systole, pressure at diastole, mean arterial pressure, pulse pressure, and continuous arterial pressure. The traditional ways of measuring these may be categorized as follows: sphygmomanometry (cuff measurement), automated sphygmomanometry, and indwelling arterial-line transduction (A-line).
The importance of continuous arterial blood pressure as a medical indicator has spurred the development of new methods of measuring it. These include external pressure transduction, photoplethysmography, and pulse-wave transit timing. To date these latter methods have been used mainly experimentally. Sphygmomanometry, the most widely used traditional method, gives pressure at systole and pressure at diastole. The automated cuff uses a machine-actuated pump for cuff inflation, and algorithms and sensors to listen for initial and unrestricted arterial flow. However the cuff methods restrict blood flow during each measurement so they are unsuited to continuous use, and the determinations of blood pressure made by many automatic cuff systems fail to meet accuracy standards. The cuff also produces discomfort to the patient, which can influence blood pressure readings.
A-lines, which are used when continuous measurement is necessary, are reasonably accurate during periods free from signal artifact, from sources such as line-crimping, blood-clotting, and contaα between the indwelling transducer and the arterial wall. However the transducer needs to be inserted surgically, and can cause thrombosis and infection. Because the method necessitates a surgical procedure, it is used sparingly, and frequently not recommended for use even when continuous pressure measurement would otherwise be desirable. The experimental methods noted all attempt to circumvent the drawbacks of the A-line by measuring continuous blood pressure externally. Both direct external pressure sensing and indirect calculation methods have been devised. The direct non-invasive methods use external pressure transduction. A pressure transducer is placed against an artery that lies just beneath the skin, such as the radial artery, and by pushing against the arterial wall senses pressure mechanically. However, because the transducer is sensing force, it is extremely subject to mechanical noise and motion artifact. Continuous measurement is problematical in that the transducer impedes blood flow. Difficulty also arises in keeping the transducer positioned properly over the artery. Thus, indirect- measurement methods have been considered.
Pulse-wave transit-time measurement is an indirect way of inferring arterial blood pressure from the velocity of the pulse wave produced at each heart cycle, however, though the velocity is related to blood pressure, the methods devised to date assume that the relationship is linear, and even if that were the case, it is probable that transit time by itself provides too little information about the pulse wave to permit the determination of blood pressure accurately. Another shortcoming of the method is that it is incapable of giving pressures at both systole and diastole, which many medical practitioners find useful.
Photoplethysmography, a technique of tracking arterial blood-volume and blood oxygen content, gives rise to the other indirect way of inferring blood pressure continuously. However, the methods based on it derive information from the volumetric data as though it were the same as blood pressure; that is, they assume that blood-pressure and blood-volume curves are similar - which is true sometimes but not in general. Furthermore, photoplethysmographic measurements are made at bodily extremities such as the earlobe or finger, and blood pressure observed at the body's periphery is not generally the same as from more central measurements.
Because the insertion of an A-line is frequently judged to be too invasive a procedure to undertake in order to determine blood pressure, and no practical non- surgical method of continuous measurement has yet supplanted it, the need for one remains. Summary of the Invention
In one aspect, the method according to the invention for determining arterial blood pressure in a subject includes detecting an EKG signal for the subject. A fiducial point on the EKG signal is selected and the blood volume versus time wave shape at a selected location on the subject's body is monitored. Instantaneous heart rate is determined from the EKG signal and arterial pressure is calculated from the instantaneous heart rate and the blood volume versus time wave shape. In one embodiment, the fiducial point is the R-wave and arterial pressure is calculated utilizing a selected change in blood volume from the blood volume versus time wave shape. It is preferred that the selected change in blood volume be in the range of 20% to 80% on the upslope on the wave shape. It is more preferred that the selected change in blood volume is in the range of 40% to 60%. The most preferred selected change in blood volume is approximately 50% on the upslope of the volume waveform. It is preferred that the selected body portion is a distal location such as a fingertip.
In another aspect, the method according to the invention for determining arterial blood pressure in a subject includes detecting an EKG for the subject and selecting a fiducial point on the EKG during the pulse period. Blood volume versus time is monitored at a selected location on the subject's body. The time difference between occurrence of the selected fiducial point on the EKG and occurrence of a selected change in blood volume at the selected body location is determined. Heart rate is determined from the EKG and arterial pressure is computed based on the time difference and heart rate. In a preferred embodiment, the fiducial point is the R-wave and the body portion is a distal location such as a fingertip. A preferred method for monitoring blood volume utilizes photoplethysmography. The computed arterial pressure may be diastolic pressure, systolic pressure, or mean arterial pressure.
In another aspect, apparatus according to the invention for determining arterial blood pressure includes EKG apparatus for detecting electrical activity of the heart. Apparatus responsive to change in blood volume may include photoplethysmography apparatus. Outputs from the EKG apparatus and the blood volume monitoring apparatus are introduced into a signal processor or computer which computes arterial blood pressure.
In yet another aspect, the signal processing and computing apparatus is adapted to detect artifacts in the blood pressure measurement and to reject such artifacts. These techniques allow for the reliable assessment of the confidence of the blood pressure calculation for each pulse. The techniques disclosed herein provide a much more reliable measure of blood pressure during times of good input signal and informs the user that there are no available measures during times of poor input signal quality. The present invention provides an improved method and apparatus for measuring arterial blood pressure continuously, non-invasively, and without the use of a blood pressure cuff. Because of the automated artifact detection and rejection, a reliable assessment of the confidence of the blood pressure computation for each pulse can be made.
Brief Description of the Drawing Fig. 1 is a schematic illustration of the apparatus of the present invention. Fig. 2 is a graph of EKG and blood volume versus time.
Description of the Preferred Embodiment
The physics of wave propagation in elastic tubes is an important factor to understand the underlying concept of the present invention. The simplest equation for the velocity of propagation of a pressure pulse in an elastic tube was first described by Moens-Kortweg who from experimental evidence and theoretical grounds established the formula
where c is the wave velocity, E and h are Young's modulus and thickness of the arterial wall, δ the density of the fluid and R the mean radius of the tube.
To eliminate the experimental difficulties of measuring the wall thickness and Young's modulus the Moens-Kortweg equation was modified by Bramwell and Hill (1922) so that the elastic behavior of the tube was expressed in terms of its pressure- volume distensibility. The formula can then be reduced to
or
where V is the initial volume of the artery, ΔV is the change in volume resulting in the pressure pulse ΔP and c is the pulse wave velocity.
The problem then involves determining a non-invasive way of measuring both the pulse wave velocity, and percent change in arterial volume. In order to accomplish this, we have chosen to use the standard EKG signal and any stable measure of blood volume versus time (such as photoplethysmography in the preferred embodiment).
The method of utilizing the EKG signal and blood volume versus time signals include first measuring the TR ^ (duration of R-wave on EKG to 50% point on volume versus time up-slope) for the i'th pulse. This duration is the sum of the time between the R-wave and the arrival of the pulse 0% point (TR 0(l)) added to the duration of the pulse 0% point to the 50% point on the up-slope (T0 _^). The inverse of TR Q is equal to the pulse velocity as defined above (or c= 1/TR 50(,)) and T0 50^ is more related to ΔV and V. Therefore the measure TR 50(,) is a measure that is related to c, ΔV and V. Then, the combined pulse velocity measure for the i'th pulse (vp^) is therefore equal to the inverse of TR 50W and the combined pulse velocity squared (v 2) is obtained by simply squaring v Q. Also the instantaneous R-R interval and thereby instantaneous heart rate for the i'th pressure pulse (RR, and IHRW respectively) are determined and used in the calculation of diastolic, systolic and mean pressures for the i'th pulse (PD(|), P(S(,) and PM^ respectively). The theoretical basis for the importance of the R-R interval or IHR in the calculation of diastolic pressure can be summarized as follows. The diastolic pressure is defined as that arterial pressure that exists at the end of the diastolic pressure decay. This exponential diastolic pressure decay starts at the closure of the aortic valve, and ends at the opening of the aortic valve. The pressure decay rate depends on a variety of factors, including the aortic pressure built up during systole, and the systemic arterial impedance (related to the stiffness of the walls of the arterial system, especially the arteriole). For a given individual, the pressure this decay falls to for any given heart beat (or diastolic pressure) is therefore related to the duration this decay is allowed to continue. This duration of decay for any given pulse is directly proportional to the instantaneous R-R interval or inversely proportional to the IHR of that pulse. Therefore, the shorter the decay duration (higher IHR), the higher the diastolic pressure is expected to be, and the longer the decay duration (lower IHR), the lower the diastolic pressure is expected to be. In summary the equations for the calculation of pressures for the i'th pressure pulse are as follows:
IHR(1) = 1/RR(1) vp(l) 2 = ( 1/TR 50(1) ) * ( 1/TR 50(1) )
PDW = ( KDv * vp(l) 2 ) + ( KDlhr * IHRW ) + KDcal
Ps(ι) = ( K-Scal * Vp(l) ) +
PM(I) = ( Ps( " PDW ) * 1/5 + PDW
In these equations, KDv, KDlhr and K^^ are constants that in the preferred embodiment are equal to 2.5, 0.5 and 35 respectively, and where KDcaι and KSca! are calibration constants. PD(,), P ^ and P M( are diastolic, systolic and mean arterial pressure respectively.
The practice of the present invention will be described in conjunction with the figures. In Fig. 1 a human subject 10 is monitored by EKG leads represented generally at 12. Those skilled in the art recognize that multiple leads are typically utilized for measuring the EKG. Photoplethysmography apparatus 14 monitors blood volume at a fingertip 16 of the subject 10. The outputs from the EKG apparatus 12 and photoplethysmography apparatus 14 are processed in a computer or signal processor 18 and produces as an output blood pressure which, as discussed above, may be diastolic pressure, systolic pressure or mean arterial pressure for each pulse. With reference to Fig. 2, the processor 18 detects the R-wave arrival. Thereafter, the blood volume measuring apparatus 14 detects the onset of a change in volume at time TR 0Q and determines the time when volume has reached the 50% (T0 ^point on the volume versus time upslope. As can be seen in Fig. 2, the time from the arrival of the pulse zero percent point (TR 0(l)) to the 50% point on the upslope (T0 ^ depends on the shape of the volume versus time curve. Because the present invention utilizes both the time from R-wave arrival to the zero percent volume change point, and from the zero percent volume change point to the 50% point, pressure determinations are more accurate than in the prior art in which either pulse arrival time or wave shape was utilized but not both in combination as in the present invention.
Another aspect of the invention includes methods for automated artifact deteαion and rejeαion thereby providing a reliable assessment of the confidence of each blood pressure calculation for each pulse. These artifact rejection methods include the calculation of two additional variables for each pulse. For the i'th pulse they are as follows: = ( )2 - P(D2 ) ' V)2 where 'vp(1) 2 is obtained by sorting five consecutive vp 2 terms { vp(,.2) 2, Vp/,.,) 2, vp(,) 2, v P(i+i) 2 > v P(i+2) 2 } an(l is tne second lowest value, 'vp(2) 2 is the median of the values, and pβ) 2 is the second highest of the values. And diffvp(l) 2 = vp(l) 2 - v p( ) 2 The algorithm for the deteαion of whether the i'th pulse is artifact involves testing if these variables are above predetermined thresholds. In this preferred embodiment, the test includes whether either qvp(l) 2 > THRESH qv diffvp(l) 2 > THRESH_diffv where the preferred values of THRESH_qv = 0.8 and THRESH_diffv = 8.0 More specifically, these variables are used in addition to the following others to determine the PD(,) calculation artifact. The algorithm includes whether: qvp(l) 2 > THRESH_qv or pD(l) < PD ΓOOLOW or
PD(1) > PD TOOHIGH or where in the preferred embodiment, PD TOOLOW = 30 and PD TOOHIGH = 150. If any of the above are true then it is deemed that the diastolic pressure for the i'th pulse (PD(,)) is n°t evaluable.
Specifically, and in like manner, the artifaα determination for Ps(]) calculation includes whether: qvp(l) 2 > THRESH_qv or diffvp(l) 2 > THRESH_diffv or
Ps(l) < PS TOOLOW or
Ps(l) > PS_TOOHIGH or
PD(ι) > Ps(.) where in the preferred embodiment, PS TOOLOW = 50 and PS_TOOHIGH = 200. If any of the above are true then it is deemed that the systolic pressure for the i'th pulse (Ps(,)) is not evaluable.
Finally and specifically, the determination if the PMQ calculation would result in artifact for the i'th pulse if:
PD(,) is not evaluable or
PS(,) is not evaluable and if either is true, then the mean pressure for the i'th pulse is deemed to be not evaluable.
What is claimed is:

Claims

1. Method for determining arterial blood pressure in a subject comprising: detecting an EKG signal for the subject; selecting a fiducial point on the EKG signal; monitoring blood volume versus time waveshape at a seleαed location on the subject's body; determining instantaneous heart rate from the EKG signal; and calculating arterial pressure from the instantaneous heart rate and the blood volume versus time waveshape.
2. The method of claim 1 wherein the fiducial point is a point on an R- wave.
3. The method of claim 2 wherein the fiducial point is the peak of the R-wave.
4. The method of claim 1 wherein the calculating step includes utilizing a selected change in blood volume on the blood volume versus time waveshape.
5. The method of claim 4 wherein the selected change in blood volume is in the range of 20% to 80% on an upslope on the wave shape.
6. The method of claim 4 wherein the selected change in blood volume is in the range of 40% to 60% on an upslope on the wave shape.
7. The method of claim 4 wherein the selected change in blood volume is approximately 50% on an upslope on the wave shape.
8. The method of claim 1 wherein the selected body portion is a distal location.
9. The method of claim 8 wherein the distal location is a fingertip.
10. The method of claim 1 wherein monitoring blood volume versus time comprises utilizing photoplethysmography.
11. Method for determining arterial blood pressure in a subject comprising: detecting an EKG for the subject; selecting a fiducial point on the EKG during a pulse; monitoring blood volume versus time at a selected location on the subject's body; determining time difference between occurrence of the selected fiducial point and occurrence of a seleαed change in blood volume at the selected body location; determining heart rate from the EKG; and computing arterial pressure based on the time difference and heart rate.
12. The method of claim 11 wherein the fiducial point is a point on an R-wave.
13. The method of claim 12 wherein the fiducial point is the peak of the R-wave.
14. The method of claim 11 wherein selected change in blood volume is in the range of 20% to 80%.
15. The method of claim 11 wherein selected change in blood volume is in the range of 40% to 60%.
16. The method of claim 11 wherein selected change in blood volume is approximately 50%.
17. The method of claim 11 wherein the seleαed body portion is a distal location.
18. The method of claim 17 wherein the distal location is a fingertip.
19. The method of claim 11 wherein monitoring blood volume versus time comprises utilizing photoplethysmography.
20. The method of claim 11 wherein arterial pressure is diastolic pressure.
21. The method of claim 11 wherein arterial pressure is systolic pressure.
22. The method of claim 11 wherein arterial pressure is mean arterial pressure.
23. The method of claim 20 wherein diastolic pressure, PDI^, is determined by computing PD(1) = ( KDv * vp(l) 2 ) + ( KDlhr * IHR,,, ) + KDcal vp(l) 2 = ( 1/TR 0(1) ) * ( 1/TR 50(1) ) where TR ^ is the time difference between occurrence of the selected fiducial point and a change in blood volume at the selected body location; KDv and KDlhr are constants and KDcal is a calibration constant; and IHR/,) is the instantaneous heart rate.
24. The method of claim 23 wherein KDv is approximately 2.5 and KDlhr is approximately 0.5.
25. The method of claim 21 wherein systolic pressure, Psw, is determined by computing wherein KSconst is a constant and K^i is a calibration constant.
26. The method of claim 25 wherein KSconst is approximately 35.
27. The method of claim 22 wherein mean arterial pressure, PM(,), is determined by computing PMØ = ( Ps(ι) " PD(I) ) * 1/3 + PD(l)
28. A method for determining arterial blood pressure in a subject comprising: detecting an EKG for the subject; selecting a fiducial point on the EKG during a pulse; monitoring blood volume versus time at a selected location on the subject's body; and determining a time difference between occurrence of the selected fiducial point and the sum of time to beginning of a volume change and the time to a selected change in blood volume which is a function of blood volume waveshape.
29. The method of claim 28 wherein the seleαed change in blood volume is approximately 50%.
30. The method of claim 29 wherein the selected fiducial point is an R- wave and the selected location of a subject's body is a fingertip.
31. The method of claim 28 wherein monitoring blood volume versus time utilizes photoplethysmography.
32. Method for artifact detection comprising: computing blood pressure for a series of pulses in a time window; determining distribution of the blood pressures for the series of pulses; and detecting artifacts from the distribution.
33. Method for detecting diastolic pressure artifact comprising: calculating qvp(,) 2 = ( p,3 2 - V p(1 2 ) / V p( where V p( 2 )is obtained by sorting { v p(.2) 2 > P(ι i) 2 > vp(l) 2 vp(l+1) ,2vp(l+2) 2} and is the second lowest value, Vp{2) the median of the volumes, and pr3) 2 is the second highest of the values; determining diastolic pressure, PDW; determining systolic pressure, ~ S^; and determining that pD(,) for an i'th pulse is an artifact if qvp(l) 2 > THRESH_qv or if PD(l) < PD_TOOLOW or if PD(l) > PD_TOOHIGH or if PD(l) > Ps(l).
34. Method for determining an artifact for systolic pressure comprising: computing qvp(l) 2; computing diffvp(l) 2 = vp(l) 2 - vp(l 1} 2; and determining systolic pressure and diastolic pressure wherein a systolic pressure calculation is an artifact if qvp(,) 2 > THRESH_qv or if diffv p 2,)> THRESH_diffv or if Ps(f) < PS_TOOLOW or if Ps(l) > PS_TOOHIGH or if PD(l) > Ps(,).
35. Method for detecting an artifact in a mean arterial pressure, PM,,), calculation comprising: determining whether PDQ is an artifact or whether PSQ is an artifact wherein the mean arterial pressure is an artifact if either PD,,) or PS(,) is an artifact.
EP97910095A 1996-10-11 1997-10-14 Non-invasive cuffless determination of blood pressure Expired - Lifetime EP0944352B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/729,445 US5865755A (en) 1996-10-11 1996-10-11 Method and apparatus for non-invasive, cuffless, continuous blood pressure determination
US729445 1996-10-11
PCT/US1997/018503 WO1998025516A1 (en) 1996-10-11 1997-10-14 Non-invasive cuffless determination of blood pressure

Publications (2)

Publication Number Publication Date
EP0944352A1 true EP0944352A1 (en) 1999-09-29
EP0944352B1 EP0944352B1 (en) 2005-09-28

Family

ID=24931062

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97910095A Expired - Lifetime EP0944352B1 (en) 1996-10-11 1997-10-14 Non-invasive cuffless determination of blood pressure

Country Status (10)

Country Link
US (2) US5865755A (en)
EP (1) EP0944352B1 (en)
JP (1) JP3671059B2 (en)
KR (1) KR100609927B1 (en)
CN (1) CN1263421C (en)
AT (1) ATE305265T1 (en)
AU (1) AU740573B2 (en)
CA (1) CA2268073C (en)
DE (1) DE69734288T2 (en)
WO (1) WO1998025516A1 (en)

Families Citing this family (171)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331162B1 (en) 1999-02-01 2001-12-18 Gary F. Mitchell Pulse wave velocity measuring device
IL128482A (en) * 1999-02-11 2003-06-24 Ultrasis Internat 1993 Ltd Method and device for continuous analysis of cardiovascular activity of a subject
AU2001221391A1 (en) 2000-01-26 2001-08-07 Vsm Medtech Ltd. Continuous blood pressure monitoring method and apparatus
IL136079A0 (en) * 2000-04-19 2001-05-20 Cheetah Medical Inc C O Pepper Method and apparatus for monitoring the cardiovascular condition, particularly the degree of arteriosclerosis in individuals
US6616613B1 (en) 2000-04-27 2003-09-09 Vitalsines International, Inc. Physiological signal monitoring system
US6893401B2 (en) * 2001-07-27 2005-05-17 Vsm Medtech Ltd. Continuous non-invasive blood pressure monitoring method and apparatus
US6517495B1 (en) 2001-09-10 2003-02-11 Ge Medical Systems Information Technologies, Inc. Automatic indirect non-invasive apparatus and method for determining diastolic blood pressure by calibrating an oscillation waveform
US6440080B1 (en) 2001-09-25 2002-08-27 Ge Medical Systems Information Technologies, Inc. Automatic oscillometric apparatus and method for measuring blood pressure
GB0123395D0 (en) * 2001-09-28 2001-11-21 Isis Innovation Locating features ina photoplethysmograph signal
US6648828B2 (en) 2002-03-01 2003-11-18 Ge Medical Systems Information Technologies, Inc. Continuous, non-invasive technique for measuring blood pressure using impedance plethysmography
US7738935B1 (en) 2002-07-09 2010-06-15 Pacesetter, Inc. Methods and devices for reduction of motion-induced noise in pulse oximetry
US6997879B1 (en) 2002-07-09 2006-02-14 Pacesetter, Inc. Methods and devices for reduction of motion-induced noise in optical vascular plethysmography
DE10249863A1 (en) * 2002-10-25 2004-05-19 Biosign Gmbh Non-invasive blood pressure measurement method in which the difference between a signal measured using an impedance cardiograph and that determined using an optical or acoustic peripheral pulse wave is determined
EP1770545A3 (en) * 2002-10-30 2014-10-08 Dpcom As Method for analysis of single pulse pressure waves
US20050148882A1 (en) * 2004-01-06 2005-07-07 Triage Wireless, Incc. Vital signs monitor used for conditioning a patient's response
US20060142648A1 (en) * 2003-01-07 2006-06-29 Triage Data Networks Wireless, internet-based, medical diagnostic system
US20050096557A1 (en) * 2003-01-08 2005-05-05 Frederick Vosburgh Noninvasive cardiovascular monitoring methods and devices
CA2520017C (en) * 2003-04-03 2013-09-10 University Of Virginia Patent Foundation System and method for passive monitoring of blood pressure and pulse rate
US7776078B2 (en) * 2003-05-22 2010-08-17 Boston Scientfic Scimed, Inc. Catheter balloon with improved retention
US7455643B1 (en) 2003-07-07 2008-11-25 Nellcor Puritan Bennett Ireland Continuous non-invasive blood pressure measurement apparatus and methods providing automatic recalibration
US7125383B2 (en) * 2003-12-30 2006-10-24 General Electric Company Method and apparatus for ultrasonic continuous, non-invasive blood pressure monitoring
US20050216199A1 (en) * 2004-03-26 2005-09-29 Triage Data Networks Cuffless blood-pressure monitor and accompanying web services interface
US20050228300A1 (en) * 2004-04-07 2005-10-13 Triage Data Networks Cuffless blood-pressure monitor and accompanying wireless mobile device
US20050228297A1 (en) * 2004-04-07 2005-10-13 Banet Matthew J Wrist-worn System for Measuring Blood Pressure
US20060009697A1 (en) * 2004-04-07 2006-01-12 Triage Wireless, Inc. Wireless, internet-based system for measuring vital signs from a plurality of patients in a hospital or medical clinic
US20050261598A1 (en) * 2004-04-07 2005-11-24 Triage Wireless, Inc. Patch sensor system for measuring vital signs
US20050228244A1 (en) * 2004-04-07 2005-10-13 Triage Wireless, Inc. Small-scale, vital-signs monitoring device, system and method
US20060009698A1 (en) * 2004-04-07 2006-01-12 Triage Wireless, Inc. Hand-held monitor for measuring vital signs
US7179228B2 (en) 2004-04-07 2007-02-20 Triage Wireless, Inc. Cuffless system for measuring blood pressure
US20060047214A1 (en) * 2004-08-24 2006-03-02 Jacob Fraden Wireless medical probe
US7502498B2 (en) 2004-09-10 2009-03-10 Available For Licensing Patient monitoring apparatus
US9820658B2 (en) 2006-06-30 2017-11-21 Bao Q. Tran Systems and methods for providing interoperability among healthcare devices
US7544168B2 (en) * 2004-09-30 2009-06-09 Jerusalem College Of Technology Measuring systolic blood pressure by photoplethysmography
US20060084878A1 (en) * 2004-10-18 2006-04-20 Triage Wireless, Inc. Personal computer-based vital signs monitor
US7658716B2 (en) * 2004-12-07 2010-02-09 Triage Wireless, Inc. Vital signs monitor using an optical ear-based module
US20060122520A1 (en) * 2004-12-07 2006-06-08 Dr. Matthew Banet Vital sign-monitoring system with multiple optical modules
US7621876B2 (en) * 2005-03-17 2009-11-24 Ge Medical Systems Information Technologies, Inc. Continuous, non-invasive technique for determining blood pressure using a transmission line model and transcutaneous ultrasound measurements
DE102005014048B4 (en) * 2005-03-23 2010-08-12 Gert Dr. Küchler Method and apparatus for noninvasive blood pressure determination
KR101013645B1 (en) * 2005-04-22 2011-02-10 엘지전자 주식회사 Mobile phone with health examination of function and method for health examination using the same
US9248034B2 (en) * 2005-08-23 2016-02-02 Advanced Cardiovascular Systems, Inc. Controlled disintegrating implantable medical devices
US7420472B2 (en) * 2005-10-16 2008-09-02 Bao Tran Patient monitoring apparatus
US7733224B2 (en) 2006-06-30 2010-06-08 Bao Tran Mesh network personal emergency response appliance
KR100745673B1 (en) * 2005-12-05 2007-08-02 한국전자통신연구원 Apparatus and method of physiology signal measurement
US20070142715A1 (en) * 2005-12-20 2007-06-21 Triage Wireless, Inc. Chest strap for measuring vital signs
US20070185393A1 (en) * 2006-02-03 2007-08-09 Triage Wireless, Inc. System for measuring vital signs using an optical module featuring a green light source
DE102006013733A1 (en) * 2006-03-24 2007-09-27 Health & Life Co., Ltd., Chung Ho City Patient blood pressure value measuring method, involves calculating systolic and diastolic blood pressure value by microprocessor through intersecting plane of temporal progress of oxygen content in blood based on calculation formula
US8323189B2 (en) 2006-05-12 2012-12-04 Bao Tran Health monitoring appliance
US8684922B2 (en) 2006-05-12 2014-04-01 Bao Tran Health monitoring system
US7539532B2 (en) 2006-05-12 2009-05-26 Bao Tran Cuffless blood pressure monitoring appliance
US7558622B2 (en) 2006-05-24 2009-07-07 Bao Tran Mesh network stroke monitoring appliance
US8500636B2 (en) 2006-05-12 2013-08-06 Bao Tran Health monitoring appliance
US8968195B2 (en) 2006-05-12 2015-03-03 Bao Tran Health monitoring appliance
US9060683B2 (en) 2006-05-12 2015-06-23 Bao Tran Mobile wireless appliance
US7539533B2 (en) * 2006-05-16 2009-05-26 Bao Tran Mesh network monitoring appliance
US8684900B2 (en) 2006-05-16 2014-04-01 Bao Tran Health monitoring appliance
US7993275B2 (en) * 2006-05-25 2011-08-09 Sotera Wireless, Inc. Bilateral device, system and method for monitoring vital signs
US9149192B2 (en) * 2006-05-26 2015-10-06 Sotera Wireless, Inc. System for measuring vital signs using bilateral pulse transit time
US7462152B2 (en) * 2006-09-07 2008-12-09 The General Electric Company Method and system utilizing SpO2 plethysmograph signal to reduce NIBP determination time
US8442607B2 (en) * 2006-09-07 2013-05-14 Sotera Wireless, Inc. Hand-held vital signs monitor
US20080082004A1 (en) * 2006-09-08 2008-04-03 Triage Wireless, Inc. Blood pressure monitor
US8449469B2 (en) * 2006-11-10 2013-05-28 Sotera Wireless, Inc. Two-part patch sensor for monitoring vital signs
ATE530111T1 (en) * 2007-02-28 2011-11-15 Medtronic Inc IMPLANTABLE TISSUE PERFUSION MEASUREMENT SYSTEM AND METHOD
US20080221461A1 (en) * 2007-03-05 2008-09-11 Triage Wireless, Inc. Vital sign monitor for cufflessly measuring blood pressure without using an external calibration
US20080221399A1 (en) * 2007-03-05 2008-09-11 Triage Wireless, Inc. Monitor for measuring vital signs and rendering video images
US7884727B2 (en) * 2007-05-24 2011-02-08 Bao Tran Wireless occupancy and day-light sensing
US8506480B2 (en) * 2007-07-11 2013-08-13 Sotera Wireless, Inc. Device for determining respiratory rate and other vital signs
US11607152B2 (en) 2007-06-12 2023-03-21 Sotera Wireless, Inc. Optical sensors for use in vital sign monitoring
US20100130875A1 (en) * 2008-06-18 2010-05-27 Triage Wireless, Inc. Body-worn system for measuring blood pressure
WO2008154647A1 (en) * 2007-06-12 2008-12-18 Triage Wireless, Inc. Vital sign monitor for cufflessly measuring blood pressure corrected for vascular index
US8602997B2 (en) * 2007-06-12 2013-12-10 Sotera Wireless, Inc. Body-worn system for measuring continuous non-invasive blood pressure (cNIBP)
WO2008154643A1 (en) * 2007-06-12 2008-12-18 Triage Wireless, Inc. Vital sign monitor for measuring blood pressure using optical, electrical, and pressure waveforms
US11330988B2 (en) 2007-06-12 2022-05-17 Sotera Wireless, Inc. Body-worn system for measuring continuous non-invasive blood pressure (cNIBP)
US20080319327A1 (en) * 2007-06-25 2008-12-25 Triage Wireless, Inc. Body-worn sensor featuring a low-power processor and multi-sensor array for measuring blood pressure
US8147416B2 (en) * 2007-08-31 2012-04-03 Pacesetter, Inc. Implantable systemic blood pressure measurement systems and methods
US8162841B2 (en) * 2007-08-31 2012-04-24 Pacesetter, Inc. Standalone systemic arterial blood pressure monitoring device
US20090118628A1 (en) * 2007-11-01 2009-05-07 Triage Wireless, Inc. System for measuring blood pressure featuring a blood pressure cuff comprising size information
US8533879B1 (en) 2008-03-15 2013-09-17 Stryker Corporation Adaptive cushion method and apparatus for minimizing force concentrations on a human body
US8161826B1 (en) 2009-03-05 2012-04-24 Stryker Corporation Elastically stretchable fabric force sensor arrays and methods of making
RU2511278C2 (en) * 2008-05-09 2014-04-10 Конинклейке Филипс Электроникс Н.В. Patient's respiration noncontact control and optic sensor for photoplethysmographic measurement
US8398556B2 (en) * 2008-06-30 2013-03-19 Covidien Lp Systems and methods for non-invasive continuous blood pressure determination
US8660799B2 (en) 2008-06-30 2014-02-25 Nellcor Puritan Bennett Ireland Processing and detecting baseline changes in signals
US20090326386A1 (en) * 2008-06-30 2009-12-31 Nellcor Puritan Bennett Ireland Systems and Methods for Non-Invasive Blood Pressure Monitoring
US8506498B2 (en) 2008-07-15 2013-08-13 Nellcor Puritan Bennett Ireland Systems and methods using induced perturbation to determine physiological parameters
US8328728B2 (en) 2008-08-22 2012-12-11 Pacesetter, Inc. Implantable hemodynamic monitor and methods for use therewith
WO2010027652A1 (en) * 2008-08-26 2010-03-11 Cardiac Pacemakers, Inc. Cardiac output estimation using pulmonary artery pressure
US20100081946A1 (en) * 2008-09-26 2010-04-01 Qualcomm Incorporated Method and apparatus for non-invasive cuff-less blood pressure estimation using pulse arrival time and heart rate with adaptive calibration
US9301697B2 (en) * 2008-09-30 2016-04-05 Nellcor Puritan Bennett Ireland Systems and methods for recalibrating a non-invasive blood pressure monitor
US9314168B2 (en) * 2008-09-30 2016-04-19 Nellcor Puritan Bennett Ireland Detecting sleep events using localized blood pressure changes
US8532751B2 (en) * 2008-09-30 2013-09-10 Covidien Lp Laser self-mixing sensors for biological sensing
US9687161B2 (en) * 2008-09-30 2017-06-27 Nellcor Puritan Bennett Ireland Systems and methods for maintaining blood pressure monitor calibration
ES2336997B1 (en) 2008-10-16 2011-06-13 Sabirmedical,S.L. SYSTEM AND APPARATUS FOR NON-INVASIVE MEASUREMENT OF BLOOD PRESSURE.
TWI425934B (en) * 2008-12-23 2014-02-11 Ind Tech Res Inst Biosignal measurement modules and methods
CN101773387B (en) * 2009-01-08 2011-12-14 香港中文大学 Body feeling network-based sleeveless driven pulse pressure measurement and automatic calibration device
KR101040653B1 (en) * 2009-01-21 2011-06-10 서울대학교산학협력단 Non-contact measuring devices of pulse wave and measuring devices of oxygen saturation and blood pressure in using same
US8216136B2 (en) 2009-03-05 2012-07-10 Nellcor Puritan Bennett Llc Systems and methods for monitoring heart rate and blood pressure correlation
US8313439B2 (en) * 2009-03-20 2012-11-20 Massachusetts Institute Of Technology Calibration of pulse transit time measurements to arterial blood pressure using external arterial pressure applied along the pulse transit path
US20100249617A1 (en) * 2009-03-31 2010-09-30 Hong Kong Applied Science and Technology Research Institute Company Limited Apparatus for determining blood pressure
US8475370B2 (en) * 2009-05-20 2013-07-02 Sotera Wireless, Inc. Method for measuring patient motion, activity level, and posture along with PTT-based blood pressure
US11896350B2 (en) 2009-05-20 2024-02-13 Sotera Wireless, Inc. Cable system for generating signals for detecting motion and measuring vital signs
US8180440B2 (en) * 2009-05-20 2012-05-15 Sotera Wireless, Inc. Alarm system that processes both motion and vital signs using specific heuristic rules and thresholds
US20100312128A1 (en) * 2009-06-09 2010-12-09 Edward Karst Systems and methods for monitoring blood partitioning and organ function
US10085657B2 (en) * 2009-06-17 2018-10-02 Sotera Wireless, Inc. Body-worn pulse oximeter
US20100324431A1 (en) * 2009-06-18 2010-12-23 Nellcor Puritan Bennett Ireland Determining Disease State Using An Induced Load
US8290730B2 (en) * 2009-06-30 2012-10-16 Nellcor Puritan Bennett Ireland Systems and methods for assessing measurements in physiological monitoring devices
US9198582B2 (en) * 2009-06-30 2015-12-01 Nellcor Puritan Bennett Ireland Determining a characteristic physiological parameter
US9687656B2 (en) * 2009-07-08 2017-06-27 Pacesetter, Inc. Arterial blood pressure monitoring devices, systems and methods for use while pacing
US20110021929A1 (en) * 2009-07-27 2011-01-27 Nellcor Puritan Bennett Ireland Systems and methods for continuous non-invasive blood pressure monitoring
US8628477B2 (en) * 2009-07-31 2014-01-14 Nellcor Puritan Bennett Ireland Systems and methods for non-invasive determination of blood pressure
US11253169B2 (en) 2009-09-14 2022-02-22 Sotera Wireless, Inc. Body-worn monitor for measuring respiration rate
US10123722B2 (en) * 2009-09-14 2018-11-13 Sotera Wireless, Inc. Body-worn monitor for measuring respiration rate
US10806351B2 (en) * 2009-09-15 2020-10-20 Sotera Wireless, Inc. Body-worn vital sign monitor
US10213159B2 (en) * 2010-03-10 2019-02-26 Sotera Wireless, Inc. Body-worn vital sign monitor
US10420476B2 (en) * 2009-09-15 2019-09-24 Sotera Wireless, Inc. Body-worn vital sign monitor
US8527038B2 (en) * 2009-09-15 2013-09-03 Sotera Wireless, Inc. Body-worn vital sign monitor
US8321004B2 (en) * 2009-09-15 2012-11-27 Sotera Wireless, Inc. Body-worn vital sign monitor
US8364250B2 (en) * 2009-09-15 2013-01-29 Sotera Wireless, Inc. Body-worn vital sign monitor
US20110066044A1 (en) 2009-09-15 2011-03-17 Jim Moon Body-worn vital sign monitor
US9220440B2 (en) * 2009-09-21 2015-12-29 Nellcor Puritan Bennett Ireland Determining a characteristic respiration rate
US9066660B2 (en) * 2009-09-29 2015-06-30 Nellcor Puritan Bennett Ireland Systems and methods for high-pass filtering a photoplethysmograph signal
US8463347B2 (en) * 2009-09-30 2013-06-11 Nellcor Puritan Bennett Ireland Systems and methods for normalizing a plethysmograph signal for improved feature analysis
WO2011110491A1 (en) 2010-03-09 2011-09-15 Sabirmedical, S.L. A non-invasive system and method for diagnosing and eliminating white coat hypertention and white coat effect in a patient
EP2364643B1 (en) * 2010-03-09 2015-07-22 BIOTRONIK SE & Co. KG Electromedical implant and monitoring system comprising the electromedical implant
US9451887B2 (en) 2010-03-31 2016-09-27 Nellcor Puritan Bennett Ireland Systems and methods for measuring electromechanical delay of the heart
US9173593B2 (en) 2010-04-19 2015-11-03 Sotera Wireless, Inc. Body-worn monitor for measuring respiratory rate
US9339209B2 (en) 2010-04-19 2016-05-17 Sotera Wireless, Inc. Body-worn monitor for measuring respiratory rate
US8888700B2 (en) 2010-04-19 2014-11-18 Sotera Wireless, Inc. Body-worn monitor for measuring respiratory rate
US9173594B2 (en) 2010-04-19 2015-11-03 Sotera Wireless, Inc. Body-worn monitor for measuring respiratory rate
US8979765B2 (en) 2010-04-19 2015-03-17 Sotera Wireless, Inc. Body-worn monitor for measuring respiratory rate
US8747330B2 (en) 2010-04-19 2014-06-10 Sotera Wireless, Inc. Body-worn monitor for measuring respiratory rate
US8898037B2 (en) 2010-04-28 2014-11-25 Nellcor Puritan Bennett Ireland Systems and methods for signal monitoring using Lissajous figures
JP5636731B2 (en) * 2010-05-10 2014-12-10 オリンパス株式会社 Blood pressure sensor system and blood pressure measurement method thereof
US9408542B1 (en) 2010-07-22 2016-08-09 Masimo Corporation Non-invasive blood pressure measurement system
RU2446738C1 (en) * 2010-10-06 2012-04-10 Виктор Михайлович Коршунов Device for measuring arterial pressure and pulse rate without cuff
US8825428B2 (en) 2010-11-30 2014-09-02 Neilcor Puritan Bennett Ireland Methods and systems for recalibrating a blood pressure monitor with memory
US9357934B2 (en) 2010-12-01 2016-06-07 Nellcor Puritan Bennett Ireland Systems and methods for physiological event marking
US9259160B2 (en) 2010-12-01 2016-02-16 Nellcor Puritan Bennett Ireland Systems and methods for determining when to measure a physiological parameter
SG10201510693UA (en) 2010-12-28 2016-01-28 Sotera Wireless Inc Body-worn system for continous, noninvasive measurement of cardiac output, stroke volume, cardiac power, and blood pressure
US8702604B2 (en) * 2011-01-31 2014-04-22 Medtronic, Inc. Detection of waveform artifact
SG192836A1 (en) 2011-02-18 2013-09-30 Sotera Wireless Inc Modular wrist-worn processor for patient monitoring
CN103491860B (en) 2011-02-18 2016-10-19 索泰拉无线公司 For measuring the optical pickocff of physiological property
US8478403B2 (en) 2011-02-23 2013-07-02 Pacesetter, Inc. Implantable systems and methods for use therewith for monitoring and modifying arterial blood pressure without requiring an intravascular pressure transducer
GB201111138D0 (en) 2011-06-30 2011-08-17 Leman Micro Devices Uk Ltd Personal health data collection
CN103099610B (en) * 2011-11-11 2015-05-13 杭州电子科技大学 Ambulatory blood pressure measuring device and method based on pulse wave transmission time difference of left brachial artery and right brachial artery
US9060695B2 (en) 2011-11-30 2015-06-23 Covidien Lp Systems and methods for determining differential pulse transit time from the phase difference of two analog plethysmographs
US8904876B2 (en) 2012-09-29 2014-12-09 Stryker Corporation Flexible piezocapacitive and piezoresistive force and pressure sensors
US8997588B2 (en) 2012-09-29 2015-04-07 Stryker Corporation Force detecting mat with multiple sensor types
US9865176B2 (en) 2012-12-07 2018-01-09 Koninklijke Philips N.V. Health monitoring system
EP2922468B1 (en) 2013-02-13 2016-06-08 Leman Micro Devices SA Non-invasive blood analysis
BR112016002488A2 (en) * 2013-08-07 2017-08-01 Koninklijke Philips Nv processor for use in a monitoring system for monitoring an individual's hemodynamic state, monitoring system for monitoring an individual's hemodynamic state, processing method for use in a monitoring system for monitoring an individual's hemodynamic state, method of monitoring to monitor an individual's hemodynamic state, and, computer program
AU2014354581B2 (en) * 2013-11-28 2019-11-07 Western Sydney University "Blood volume monitor"
WO2015120330A1 (en) 2014-02-06 2015-08-13 Sotera Wireless, Inc. Body-worn system for continuous, noninvasive measurement of vital signs
WO2016029196A1 (en) 2014-08-22 2016-02-25 Sotera Wirless, Inc. System for calibrating a blood pressure measurement based on vascular transit of a pulse wave
KR101517072B1 (en) * 2014-10-08 2015-05-04 이의호 Method to measure glomerular filtration rate of the kidney and device thereof
WO2016065469A1 (en) 2014-10-27 2016-05-06 Jesse Goodman System and method for monitoring aortic pulse wave velocity and blood pressure
TWI545516B (en) * 2015-09-16 2016-08-11 國立交通大學 System and method for blood pressure measurement, a computer program product using the method, and a computer-readable recording medium thereof
US10758185B2 (en) 2015-11-25 2020-09-01 Texas Instruments Incorporated Heart rate estimation apparatus using digital automatic gain control
US10321831B2 (en) 2015-11-25 2019-06-18 Texas Instruments Incorporated Heart rate estimation apparatus with state sequence optimization
WO2017179694A1 (en) 2016-04-15 2017-10-19 オムロン株式会社 Biological information analysis device, system, program, and biological information analysis method
WO2017211866A1 (en) * 2016-06-07 2017-12-14 Aalborg Universitet Method and system for measuring aortic pulse wave velocity
US10729381B2 (en) 2016-06-24 2020-08-04 Texas Instruments Incorporated Photoplethysmogram with motion artifact compensation
EP3524137B1 (en) * 2016-10-21 2024-02-21 Huawei Technologies Co., Ltd. Calibration method for blood pressure measuring device, and blood pressure measuring device
WO2018095083A1 (en) 2016-11-22 2018-05-31 浙江脉联医疗设备有限公司 Pulse wave propagation time correction method
TWI615127B (en) * 2017-01-17 2018-02-21 正崴精密工業股份有限公司 A method for measuring blood pressure and device thereof
WO2019055121A1 (en) * 2017-09-13 2019-03-21 Battelle Memorial Institute Wearable health monitoring device
CN109480805B (en) 2017-09-13 2023-08-15 三星电子株式会社 Biological information measuring apparatus and biological information measuring method
CN108670231B (en) * 2018-03-14 2022-02-15 深圳竹信科技有限公司 Blood pressure measuring method, terminal and computer readable storage medium
US11357412B2 (en) 2018-11-20 2022-06-14 42 Health Sensor Holdings Ltd. Wearable cardiovascular monitoring device
US11717186B2 (en) 2019-08-27 2023-08-08 Medtronic, Inc. Body stability measurement
US11375905B2 (en) 2019-11-21 2022-07-05 Medtronic, Inc. Performing one or more pulse transit time measurements based on an electrogram signal and a photoplethysmography signal
US20210275110A1 (en) 2019-12-30 2021-09-09 RubyElf, LLC Systems For Synchronizing Different Devices To A Cardiac Cycle And For Generating Pulse Waveforms From Synchronized ECG and PPG Systems
WO2024035354A1 (en) * 2022-08-11 2024-02-15 Aygo Sağlik Hi̇zmetleri̇ Bi̇li̇şi̇m Ve Danişmanlik Li̇mi̇ted Şi̇rketi̇ Blood pressure meter

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4030485A (en) * 1974-11-12 1977-06-21 Glenfield Warner Method and apparatus for continuously monitoring systolic blood pressure
US4295471A (en) * 1979-05-25 1981-10-20 Kaspari William J Non-invasive vascular waveform transducer and apparatus
US4425920A (en) * 1980-10-24 1984-01-17 Purdue Research Foundation Apparatus and method for measurement and control of blood pressure
US4418700A (en) * 1981-03-11 1983-12-06 Sylvia Warner Method and apparatus for measurement of heart-related parameters
GB8401500D0 (en) * 1984-01-20 1984-02-22 Johnson Matthey Plc Measurement of physiological parameter
USRE33834E (en) * 1984-05-10 1992-03-03 Sylvia Warner Heart-related parameters monitoring apparatus
US4834107A (en) * 1984-05-10 1989-05-30 Sylvia Warner Heart-related parameters monitoring apparatus
GB8422770D0 (en) * 1984-09-10 1984-10-17 Pulse Time Products Ltd Indicating blood pressure
DE3533912A1 (en) * 1985-09-23 1987-04-02 Schmid Walter Sphygmomanometer
US5054493A (en) * 1986-01-31 1991-10-08 Regents Of The University Of Minnesota Method for diagnosing, monitoring and treating hypertension
DE3787725T2 (en) * 1986-12-25 1994-02-03 Colin Electronics BLOOD PRESSURE CONTROL SYSTEM.
US4869262A (en) * 1987-02-02 1989-09-26 Pulse Time Products Limited Device for displaying blood pressure
DE3807672A1 (en) * 1988-03-09 1989-09-21 Vectron Ges Fuer Technologieen METHOD FOR CONTINUOUSLY MEASURING BLOOD PRESSURE ON HUMAN AND BLOOD PRESSURE MEASURING DEVICE FOR CARRYING OUT THE METHOD
US4880013A (en) * 1988-03-24 1989-11-14 Chio Shiu Shin Method and apparatus for determining blood pressure and cardiovascular condition
US4889262A (en) * 1988-06-07 1989-12-26 L'oreal, S. A. Locking system for pump dispenser
US5111817A (en) * 1988-12-29 1992-05-12 Medical Physics, Inc. Noninvasive system and method for enhanced arterial oxygen saturation determination and arterial blood pressure monitoring
US5033472A (en) * 1989-02-23 1991-07-23 Nihon Kohden Corp. Method of and apparatus for analyzing propagation of arterial pulse waves through the circulatory system
US5036857A (en) * 1989-10-26 1991-08-06 Rutgers, The State University Of New Jersey Noninvasive diagnostic system for coronary artery disease
EP0443267A1 (en) * 1990-02-23 1991-08-28 Sentinel Monitoring, Inc. Method and apparatus for continuous non-invasive blood pressure monitoring
US5152296A (en) * 1990-03-01 1992-10-06 Hewlett-Packard Company Dual-finger vital signs monitor
US5140990A (en) * 1990-09-06 1992-08-25 Spacelabs, Inc. Method of measuring blood pressure with a photoplethysmograph
JPH05207978A (en) * 1992-01-24 1993-08-20 Nec Corp Instrument for measuring fluctuation in blood pressure in non-restrained training
US5368040A (en) * 1993-08-02 1994-11-29 Medtronic, Inc. Apparatus and method for determining a plurality of hemodynamic variables from a single, chroniclaly implanted absolute pressure sensor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9825516A1 *

Also Published As

Publication number Publication date
ATE305265T1 (en) 2005-10-15
AU740573B2 (en) 2001-11-08
DE69734288T2 (en) 2006-07-06
US5857975A (en) 1999-01-12
KR100609927B1 (en) 2006-08-04
WO1998025516A1 (en) 1998-06-18
AU4755697A (en) 1998-07-03
KR20000049078A (en) 2000-07-25
CA2268073C (en) 2005-08-23
DE69734288D1 (en) 2005-11-03
US5865755A (en) 1999-02-02
EP0944352B1 (en) 2005-09-28
JP2001504362A (en) 2001-04-03
CN1263421C (en) 2006-07-12
CA2268073A1 (en) 1998-06-18
CN1237885A (en) 1999-12-08
JP3671059B2 (en) 2005-07-13

Similar Documents

Publication Publication Date Title
US5865755A (en) Method and apparatus for non-invasive, cuffless, continuous blood pressure determination
US6599251B2 (en) Continuous non-invasive blood pressure monitoring method and apparatus
US6893401B2 (en) Continuous non-invasive blood pressure monitoring method and apparatus
US9204857B2 (en) System and method for monitoring hemodynamic state
US6120459A (en) Method and device for arterial blood pressure measurement
Chung et al. Non-invasive continuous blood pressure monitoring: a review of current applications
KR100821409B1 (en) Method and apparatus for measuring cardiac flow output
US6652466B2 (en) Blood flow volume measurement method and vital sign monitoring apparatus
US7137955B2 (en) Methods and systems for distal recording of phonocardiographic signals
Ye et al. Estimation of systolic and diastolic pressure using the pulse transit time
EP0365614B1 (en) Cardiovascular pressure and condition method and apparatus
US9591976B2 (en) Method and apparatus for measuring blood volume
US20080262362A1 (en) Non-invasive blood pressure determination method
US20220296113A1 (en) Non-invasive blood pressure measurement
EP3545832B1 (en) Correction method for pulse wave propagation time related to diastolic blood pressure and systolic blood pressure
KR101549619B1 (en) Method and apparatus for detecting measurement location of blood pressure
US6440079B1 (en) Superior-and-inferior-limb blood-pressure index measuring apparatus
AU772973B2 (en) Non-invasive cuffless determination of blood pressure
WO1999039634A1 (en) Method and device for arterial blood pressure measurement
EP4275611A1 (en) Continuous blood pressure measurement system and method
Mafi Blood pressure estimation using oscillometric pulse morphology
L Antonova Recent patents on accuracy of blood pressure measurement
Chellathurai Development of a new device to measure finger's mean arterial pressure
Perfetto et al. Arterial blood pressure waveform analysis and its applications in the assessment of vasovagal syncope*
Jones et al. Monitoring the peripheral vascular system

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990422

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 19990423;LT PAYMENT 19990423;LV PAYMENT 19990423;RO PAYMENT 19990423;SI PAYMENT 19990423

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CRITIKON COMPANY L.L.C.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CRITIKON COMPANY, L.L.C.

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20021007

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DXTEK, INC.

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050928

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050928

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050928

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20050928

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20051014

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20051031

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20051031

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20051102

Year of fee payment: 9

Ref country code: AT

Payment date: 20051102

Year of fee payment: 9

REF Corresponds to:

Ref document number: 69734288

Country of ref document: DE

Date of ref document: 20051103

Kind code of ref document: P

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20051125

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20051128

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20051130

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20051228

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20051228

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20051228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060108

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060228

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: PATENTANWAELTE SCHAAD, BALASS, MENZL & PARTNER AG

26N No opposition filed

Effective date: 20060629

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20061014

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20061031

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20061031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070501

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20061014

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20070629

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20061014

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20061031